Abstract
Colorectal cancer screening and primary CVD prevention have general and selectively applied updates. This review also covers medical services to avoid and those without sufficient evidence to recommend.
MeSH terms
-
Advisory Committees
-
Aspirin / administration & dosage
-
Breast Feeding
-
Cardiovascular Diseases / prevention & control
-
Colorectal Neoplasms / diagnosis
-
Dose-Response Relationship, Drug
-
Female
-
Folic Acid / therapeutic use
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
-
Latent Tuberculosis / diagnosis
-
Male
-
Mass Screening / methods
-
Mass Screening / standards*
-
Neural Tube Defects / prevention & control
-
Platelet Aggregation Inhibitors / administration & dosage
-
Practice Guidelines as Topic*
-
Pregnancy
-
Primary Health Care / standards*
-
Primary Prevention
-
Prostate-Specific Antigen / blood
-
Prostatic Neoplasms / diagnosis
-
Risk Assessment
-
Syphilis / diagnosis
-
United States
-
Vitamin B Complex / therapeutic use
Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Platelet Aggregation Inhibitors
-
Vitamin B Complex
-
Folic Acid
-
Prostate-Specific Antigen
-
Aspirin